Francesco Calzaferri Selected Research

Francesco Calzaferri Research Topics

3	Inflammation (Inflammations) 01/2024 - 11/2020
2	Neuroinflammatory Diseases 01/2021 - 11/2020
2	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 11/2020
1	Schizophrenia (Dementia Praecox) 01/2023
1	Neurobehavioral Manifestations 01/2023
1	Status Epilepticus (Complex Partial Status Epilepticus) 01/2022
1	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 01/2020
1	Sarcoma (Soft Tissue Sarcoma) 01/2020

3	Adenosine Triphosphate (ATP)IBA 01/2023 - 01/2021
3	Purinergic P2X7 ReceptorsIBA 01/2022 - 01/2020
2	LipopolysaccharidesIBA 01/2024 - 01/2022
1	InflammasomesIBA 01/2024
1	Retinaldehyde (Retinal)IBA 01/2024
1	Midazolam (Versed)FDA LinkGeneric 01/2022
1	Anticonvulsants (Antiepileptic Drugs)IBA 01/2022
1	Carbamazepine (Tegretol)FDA LinkGeneric 01/2022
1	ConvulsantsIBA 01/2022
1	Kainic Acid (Kainate)IBA 01/2022
1	Lorazepam (Ativan)FDA LinkGeneric 01/2022
1	ITH15004IBA 01/2022
1	Minocycline (Cyclops)FDA LinkGeneric 01/2022
1	Phenytoin (Dilantin)FDA LinkGeneric 01/2022
1	NucleotidesIBA 01/2021
1	purineIBA 01/2021
1	Purinergic Receptors (Receptors, Purine)IBA 01/2021
1	Superoxide Dismutase-1IBA 01/2020
1	DNA (Deoxyribonucleic Acid)IBA 01/2020
1	Proteins (Proteins, Gene)FDA Link 01/2020

2	Therapeutics 01/2022 - 01/2020
1	Drug Therapy (Chemotherapy) 01/2022